Institutional subscriptions are print only and do not include online access. For online access, please contact Ovid.
Member pricing is for AAN members only. To become an AAN member, visit AAN.com/membership or call 800-361-0633 (outside North America call 301-223-2300).
Country:
*Institutional subscriptions are Print only and do not include online access. For online access, please contact Ovid.
Anti-Cancer Drugs is a leading international journal focused on the latest clinical and experimental research related to anti-cancer therapeutics. We welcome submissions on topics such as anti-cancer drug design, drug delivery systems, pharmacology, and both hormonal and biological treatment modalities, alongside comprehensive evaluations of chemotherapy. Here's what you can expect:
Cutting-Edge Research: Stay informed with the latest breakthroughs in anti-cancer therapies, including pioneering studies on both conventional and innovative treatment modalities.
Comprehensive Coverage: The journal covers a wide range of topics from drug design and delivery systems to pharmacological studies, offering a complete view of advancements in cancer therapeutics.
Expert Peer Review: Each submission is rigorously evaluated by a panel of distinguished experts, ensuring high-quality, reliable research findings.
Wide Access: Subscribers gain complete online access to current and archived issues, facilitating extensive research and knowledge accumulation.
Global Audience: As a leading international journal, Anti-Cancer Drugs disseminates knowledge that is integral for professionals around the world, supporting oncologists, pharmacists, and researchers alike.
Our mission is to advance the field of oncology by publishing pioneering studies on both toxic and non-toxic anti-cancer agents. The journal's scope spans conventional cytotoxic chemotherapy and innovative hormonal or biological responses, including interleukins and immunotherapy.
Subscription Details: An individual subscription to Anti-Cancer Drugs includes 10 issues per year with complete online access to all current and archived content.
This esteemed journal serves as a critical resource for oncologists, pharmacists, and cancer researchers committed to staying at the forefront of therapeutic advancements in cancer treatment
ISBN/ISSN
1473-5741
Product Format
Online Journal Only
Publication Frequency
Published 10 times per year
Paul Dent Ph.D
Professor Paul Dent, VCU Massey Cancer Center, Richmond VA, USA
Peer-Reviewed Articles: Expect only the highest standards of quality with our peer-reviewed articles. Each submission undergoes a rigorous review process by esteemed professionals, providing you with trustworthy and reliable information.
Expertly Curated Content: Each issue is carefully curated by the journal’s Editor-in-Chief, ensuring the content is highly relevant to the needs of your specialty.
Comprehensive Archive of Back Issues: Gain access to an extensive archive of past issues, providing a rich repository of valuable medical knowledge. Whether you’re researching case studies, reviewing updates on medical guidelines, or catching up on cutting-edge research, our archive has you covered.
Free Email Table of Contents and Latest Article Alerts: Never miss an issue or article with our free email alerts. Get the latest table of contents delivered straight to your inbox (eTOCS) or notification of new articles as they publish, ensuring you never miss crucial updates or groundbreaking studies. Tailored for busy professionals, these alerts help you stay informed.
Responsive Web Design: Our journal's intuitive web design adapts seamlessly to any device, be it a desktop, tablet, or smartphone. Access content anytime, anywhere, and have vital information at your fingertips whether you’re in the office, at home, or on the go.
10 Issues / 12 months
($10.00/issue)
Item already added to cart.
Avoid future price increases! Lock in your rate by opting-in to a 3-year term.
20 Issues / 24 months
(/issue)
Item already added to cart.
Avoid future price increases! Lock in your rate by opting-in to a 3-year term.
30 Issues / 36 months
(/issue)
Item already added to cart.
Avoid future price increases! Lock in your rate by opting-in to a 3-year term.
$
$958.00
Item already added to cart.
Not Purchasable:
Not done configuring
Buy from another retailer
See what you are missing in the latest issue of Anti-Cancer Drugs Online
Your cart cannot contain products from multiple regions.
If you click continue, items in the cart from the previous
region will be removed. To keep items from the previous
region in your cart, click cancel.
This item is not related to current region.
AAOS members get an exclusive discount. Please click continue to log in as an AAOS member.
AHA members get an exclusive discount. Please click continue to log in as an AHA member.